We are committed to finding a cure for WM.

Archive

Article: The Rarity of WM Challenging

Treatment options are limited for patients with Waldenstrom’s macroglobulinemia (WM), says Morie A. Gertz, MD. Combination therapies offer a potential solution, but the rarity of the disease is an obstacle. The disease occurs in roughly 4 patients per million, per… Continue reading

Health Canada Approves IMBRUVICA

IMBRUVICA® is an oral, once-daily, single-agent therapy associated with a durable response in patients with this rare B-cell lymphoma

TORONTOMay 12, 2016 /CNW/ – Janssen Inc. announced today that Health Canada has issued… Continue reading